US Bancorp

SEC CIK: 0000036104
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

AMAM holding history

Ambrx Biopharma, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMAM overview All 13F holders of AMAM Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2023

Holdings of AMAM by US Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−906−100.0%	Sold out	Holders
Q4 2023	906	$12.9K	<0.1%	−112−11.0%	Reduced	Holders
Q3 2023	1,018	$11.7K	<0.1%	00.0%	Unchanged	Holders
Q2 2023	1,018	$16.8K	<0.1%	+1,018	New	Holders